In recent experimental gene therapy, the wild-type cln7 gene was delivered with an AAV vector into a cln7−/− mouse model of CLN7 Batten disease (Table 1). This evidence concerns the gene MFSD8 and juvenile neuronal ceroid lipofuscinosis.